CRON

2.73

0.36% -0.01

Handel nachbörslich: 2.73

Cronos Group Inc (CRON)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.74

Offen:

$2.74

24-Stunden-Volumen:

1.09M

Relative Volume:

0.74

Marktkapitalisierung:

$1.02B

Einnahmen:

$146.59M

Nettoeinkommen (Verlust:

$-2.93M

KGV:

-111.89

EPS:

-0.0244

Netto-Cashflow:

$-190.40K

1W Leistung:

+4.60%

1M Leistung:

+1.87%

6M Leistung:

+10.08%

1J Leistung:

+34.48%

1-Tages-Spanne:

$2.72

$2.775

1-Wochen-Bereich:

$2.61

$2.775

52-Wochen-Spanne:

$1.84

$3.43

Cronos Group Inc Stock (CRON) Company Profile

Firmenname

Cronos Group Inc

Sektor

Healthcare (1111)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

(416) 504-0004

Adresse

4491 CONCESSION RD 12, STAYNER, ON

Mitarbeiter

610

Twitter

@cronosgroup

Nächster Verdiensttermin

2026-05-11

Neueste SEC-Einreichungen

CRON's Discussions on Twitter

Compare CRON vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRON Cronos Group Inc	2.73	1.02B	146.59M	-2.93M	-190.40K	-0.0244
TAK Takeda Pharmaceutical Co Adr	15.87	51.34B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.24	41.15B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	34.61	39.67B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	80.23	34.09B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	578.43	24.13B	3.17B	1.29B	1.01B	27.09

Cronos Group Inc Stock (CRON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-27	Eingeleitet	Canaccord Genuity	Buy
2022-11-02	Eingeleitet	Bernstein	Mkt Perform
2022-07-28	Hochstufung	Canaccord Genuity	Hold → Buy
2022-05-11	Hochstufung	CIBC	Neutral → Sector Outperform
2022-03-22	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-27	Hochstufung	Jefferies	Underperform → Hold
2021-11-18	Fortgesetzt	BofA Securities	Underperform
2021-04-28	Fortgesetzt	BofA Securities	Underperform
2021-02-22	Herabstufung	CIBC	Sector Outperform → Neutral
2020-06-24	Hochstufung	Raymond James	Mkt Perform → Outperform
2020-04-27	Herabstufung	Raymond James	Outperform → Mkt Perform
2020-04-14	Herabstufung	Piper Sandler	Overweight → Neutral
2020-04-02	Herabstufung	BofA/Merrill	Buy → Neutral
2020-03-31	Herabstufung	Canaccord Genuity	Hold → Sell
2020-03-04	Hochstufung	MKM Partners	Neutral → Buy
2020-03-03	Herabstufung	Stifel	Buy → Hold
2019-10-18	Hochstufung	Stifel	Hold → Buy
2019-09-20	Eingeleitet	MKM Partners	Neutral
2019-09-05	Hochstufung	BMO Capital Markets	Underperform → Market Perform
2019-08-13	Eingeleitet	Piper Jaffray	Overweight
2019-08-09	Hochstufung	Canaccord Genuity	Sell → Hold
2019-06-28	Eingeleitet	Consumer Edge Research	Equal Weight
2019-06-06	Eingeleitet	Stifel	Hold
2019-06-05	Hochstufung	BofA/Merrill	Underperform → Buy
2019-04-17	Eingeleitet	BofA/Merrill	Underperform
2019-03-27	Herabstufung	Canaccord Genuity	Hold → Sell
2019-02-25	Eingeleitet	Jefferies	Underperform
2019-01-18	Eingeleitet	CIBC	Sector Outperform

Alle ansehen

Cronos Group Inc Aktie (CRON) Neueste Nachrichten

May 22, 2026

Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now - The Motley Fool

May 22, 2026

Does Stronger Q1 Profitability And Spinach Vape Gains Change The Bull Case For Cronos Group (TSX:CRON)? - simplywall.st

May 20, 2026

Cronos Group Inc. stock rises Wednesday, outperforms market - MarketWatch

May 20, 2026

Cronos Group (CRON) price target increased by 10.71% to 3.79 - MSN

May 20, 2026

May 19, 2026

Cannabis Stocks Draw Attention As Rescheduling Debate Gains Momentum - Kalkine Media

May 19, 2026

May 18, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

May 18, 2026

Cronos Expands Spinach STIX Pre Rolls And Chases Canadian Market Share - Yahoo Finance

May 18, 2026

May 17, 2026

Cronos Group stock (CA22717L1013): cannabis player shifts focus as Q1 loss widens - AD HOC NEWS

May 17, 2026

May 16, 2026

Cronos targets Canadelaar close in summer 2026 while renewing $50M buyback - MSN

May 16, 2026

Cronos Group (CRON) Q1 earnings meet estimates - MSN

May 16, 2026

May 15, 2026

Cronos Group Inc. stock falls Friday, underperforms market - MarketWatch

May 15, 2026

Is Cronos Group stock a buy? - Cantech Letter

May 15, 2026

May 14, 2026

Cronos: Strong Q1 Earnings Driven By International Cannabis Sales - Seeking Alpha

May 14, 2026

Cronos Group (CRON) officer exercises 10,597 RSUs, with 5,199 shares for tax - Stock Titan

May 14, 2026

Cronos Group (CRON) officer receives 10,367 shares as RSUs vest - Stock Titan

May 14, 2026

Cronos Group (CRON) officer exercises RSUs and withholds shares to cover taxes - Stock Titan

May 14, 2026

Cronos Group (CRON) officer settles RSUs and tax withholding shares - Stock Titan

May 14, 2026

May 13, 2026

Cronos Group Inc. stock falls Wednesday, underperforms market - MarketWatch

May 13, 2026

Short-Seller Left Didn’t Make ‘Sense,’ Cronos CEO Testifies - Bloomberg.com

May 13, 2026

Cronos: Excellent M&A And Favorable Valuation Make This A Buy (Upgrade) (NASDAQ:CRON) - Seeking Alpha

May 13, 2026

Cronos Group stock (CA22717L1013): Q1 revenue hits record $45.2M amid rescheduling boost - AD HOC NEWS

May 13, 2026

May 12, 2026

Short-Seller Left ‘Didn’t Make Much Sense,’ Cronos CEO Testifies - Bloomberg.com

May 12, 2026

Cronos Group (CRON) executive converts 3,118 RSUs into common shares, holding 211,555 shares - Stock Titan

May 12, 2026

Cronos Group (NASDAQ: CRON) officer converts RSUs into 20,470 common shares - Stock Titan

May 12, 2026

Cronos Group (CRON) officer exercises RSUs, uses 4,774 shares for taxes - Stock Titan

May 12, 2026

TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.02 - Moomoo

May 12, 2026

Cronos Group Reports 2026 First Quarter Results - Sahm

May 12, 2026

Cronos Group Announces New Share Buyback After Strong Quarter - The Globe and Mail

May 12, 2026